7-65398955-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152626.4(ZNF92):c.841G>A(p.Glu281Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,613,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
ZNF92
NM_152626.4 missense
NM_152626.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.06
Genes affected
ZNF92 (HGNC:13168): (zinc finger protein 92) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription, DNA-templated. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.054431975).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF92 | NM_152626.4 | c.841G>A | p.Glu281Lys | missense_variant | 4/4 | ENST00000328747.12 | NP_689839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF92 | ENST00000328747.12 | c.841G>A | p.Glu281Lys | missense_variant | 4/4 | 1 | NM_152626.4 | ENSP00000332595 | P2 | |
ZNF92 | ENST00000357512.3 | c.745G>A | p.Glu249Lys | missense_variant | 3/3 | 1 | ENSP00000350113 | A2 | ||
ZNF92 | ENST00000450302.2 | c.634G>A | p.Glu212Lys | missense_variant | 3/3 | 1 | ENSP00000396126 | |||
ZNF92 | ENST00000431504.1 | c.613G>A | p.Glu205Lys | missense_variant | 2/2 | 1 | ENSP00000400495 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151822Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151822
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000404 AC: 1AN: 247784Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134614
GnomAD3 exomes
AF:
AC:
1
AN:
247784
Hom.:
AF XY:
AC XY:
1
AN XY:
134614
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461238Hom.: 0 Cov.: 34 AF XY: 0.00000550 AC XY: 4AN XY: 726912
GnomAD4 exome
AF:
AC:
10
AN:
1461238
Hom.:
Cov.:
34
AF XY:
AC XY:
4
AN XY:
726912
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151822Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74146
GnomAD4 genome
AF:
AC:
1
AN:
151822
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74146
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2023 | The c.841G>A (p.E281K) alteration is located in exon 4 (coding exon 4) of the ZNF92 gene. This alteration results from a G to A substitution at nucleotide position 841, causing the glutamic acid (E) at amino acid position 281 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.;.
MutationTaster
Benign
N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
B;B;.;.
Vest4
MutPred
Gain of methylation at E281 (P = 0.0038);.;.;.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at